Friday, May 25, 2012

Biotech rivalry: Heritage favors Bay Area, but is Boston the future?

(San Francisco Business Times subscription required.)

With increasing amounts of seed, startup and early-stage venture cash, a $10 billion state program and a mixture of biotech startups, mature Big Pharma companies and academic interests within walking distance of each other, the Boston area is surging.

No comments:

Post a Comment